Skip to content
Home/GPs/Qubis
Qubis

Qubis

Belfast, United Kingdom·Founded 1984··qubis.co.uk

QUBIS Ltd is the technology-transfer and spin-out investment company of Queen's University Belfast, wholly owned by the University and incorporated in 1984. From its Belfast base it takes direct equity stakes in university spin-outs across life sciences, digital, engineering, environmental and scientific technology, and has helped create more than 100 companies. Not FCA-authorised as an AIFM, it invests as a balance-sheet evergreen holder and reported net assets of GBP 165.1m in its 2024 accounts.

AUM
€193M
Funds
1
vintages 1984
Portfolio
43
Exits
10

Key facts

HQBelfast, United Kingdom
Founded1984
Employees7+

Recent exits

Titan IC Systems Ltd
Titan IC Systems Ltd
Cybersecurity2020 · 12yr hold
Fusion Antibodies Plc
Fusion Antibodies Plc
Biotech2017 · 15yr hold
PathXL Ltd
HealthTech2016 · 9yr hold
Trucorp Ltd
MedTech2016 · 14yr hold

Coverage notes

1 fund tracked, 53 portfolio companies (43 active · 10 realized). Verified weekly from public filings and deal announcements.

Sector breakdown

53 companies
Biotech
17 · 32%
Industrials
8 · 15%
HealthTech
7 · 13%
ClimateTech
4 · 8%
Software
3 · 6%
AI/ML
2 · 4%
Data & Analytics
2 · 4%
Business Services
2 · 4%

Funds & portfolio

Every fund Qubis has raised, with its portfolio companies. Hand-checked from public filings.

1 fund
QUBIS LtdEvergreen
1984 · 42yr€193M43 active · 10 realized

Unrealized

43 held
Acksen LtdActive
IndustrialsUK· Entry 1995
AI/MLUK· Entry 2013
HealthTechUK· Entry 2019
AilsebioActive
BiotechUK· Entry 2021
HealthTechUK· Entry 2004
BiotechUK· Entry 2021
Data & AnalyticsUK· Entry 2009
BiotechUK· Entry 2021
Data & AnalyticsUK· Entry 2019
Biocolor Ltd
Biocolor LtdActive
BiotechUK· Entry 1993
BirotaActive
Business ServicesUK· Entry 2024
BiotechUK· Entry 2022
FintechUK· Entry 2023
Catagen Ltd
Catagen LtdActive
ClimateTechUK· Entry 2013
HealthTechUK· Entry 2014
HealthTechUK· Entry 2012
BiotechUK· Entry 2019
BiotechUK· Entry 2022
IndustrialsUK· Entry 2005
Eventmap Ltd
Eventmap LtdActive
SoftwareUK· Entry 2002
FjordStrongActive
IndustrialsUK· Entry 2019
GeneratRActive
BiotechUK· Entry 2022
Gran Lab LtdActive
BiotechUK· Entry 2024
ClimateTechUK· Entry 2015
InnovaScopeActive
MedTechUK· Entry 2025
LoyalBe
LoyalBeActive
FintechUK· Entry 2025
Business ServicesUK· Entry 1987
BiotechUK· Entry 2022
Nuada
NuadaActive
ClimateTechUK· Entry 2013
ClimateTechUK· Entry 2019
HealthTechUK· Entry 2021
BiotechUK· Entry 2016
ReNewVaxActive
BiotechUK· Entry 2025
ReproGo
ReproGoActive
HealthTechUK· Entry 2020
RetinizeActive
Deep TechUK· Entry 2025
Sengenia Ltd
Sengenia LtdActive
IndustrialsUK· Entry 2008
Sensalience
SensalienceActive
IndustrialsUK· Entry 2023
SignaCor
SignaCorActive
BiotechUK· Entry 2024
AI/MLUK· Entry 2018
StimOxyGen
StimOxyGenActive
BiotechUK· Entry 2025
IndustrialsUK· Entry 2011
BiotechUK· Entry 2019
BiotechUK· Entry 2019

Realized

10 exits
TMTUK· Entry 1990
Trade Saleto
Andor TechnologyExited 2004
IndustrialsUK· Entry 1990
IPO
IndustrialsUK· Entry 2001
Trade Saleto
BiotechUK· Entry 2002
IPO
Kainos Group PlcExited 2015
IT ServicesUK· Entry 1987
IPO
SoftwareUK· Entry 1996
Trade Saleto
Meridio LtdExited 2007
SoftwareUK· Entry 2001
Trade Saleto
PathXL LtdExited 2016
HealthTechUK· Entry 2007
Trade Saleto
CybersecurityUK· Entry 2008
Trade Saleto
Trucorp LtdExited 2016
MedTechUK· Entry 2002
Trade Saleto
Track Qubis

Saved GPs appear in your watchlist, one click from your workspace.

About Qubis

Qubis is a British private equity and investment platform with capital deployed across 2 active fund vehicles, headquartered in London. The firm operates across multiple alternative strategies, with capital deployed into European businesses across TMT, healthcare, software, industrials, business services and consumer.

Investment thesis

Qubis operates across complementary alternative investment strategies, deploying capital into European businesses across TMT, healthcare, software, industrials, business services and consumer. The multi-strategy platform enables diversified capital deployment across the business lifecycle from venture and growth equity to mid-cap buyouts, with capital sourced from institutional limited partners and selective family-office capital across the United Kingdom and broader European market.

Recent activity

Recent realised exits include Meridio Ltd (TMT, 2021) and Tactility Factory (TMT, 2017). The platform tracks 2 fund vehicles, 104 active portfolio companies and 2 realised exits across the strategy's history. Detailed buyer names and multiple data available on Pro at €29/month.

Get the full picture on Qubis.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Save this GP to your watchlist
Saved searches that re-run your sourcing filters in one click
Geography breakdown across 1 geography
Exit buyers and MOIC on every realized deal (Pro)
Export, compare GPs side by side (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Last updated August 2026 · Sourced from public filings · Report an issue